On March 7, 2022, the FDA published Abbott Nutrition’s voluntary recall on one extra lot of Similac® powder formula in addition to lots of Similac®, Alimentum® and EleCare® powder formula that were recalled in February. The recall was originally initiated due to complaints of bacterial infection in four infants who were ingesting formula made in one of Abbott’s manufacturing facilities and now expanded after there was a reported bacterial infection death of an infant who was also ingesting the formula. Routine testing found Cronobacter sakazakii, a type of bacteria, in an Abbott plant in Sturgis, Mich in a non-product contact area. This bacteria can cause rare but serious infections in infants such as dangerous blood infection called sepsis, spinal cord inflammation, or meningitis. Symptoms of infection may include temperature changes, poor feeding, excessive crying, low energy, jaundice, grunting breaths, abnormal body movements, rash or blood in the urine or stool. If patients experience any of the listed symptoms, they are to seek immediate care and report symptoms to the patient’s health care provider. Customers in possession of powder formulas should check the lots of the products and return the recalled products as instructed by the manufacturer. The FDA continues to investigate the case and so far, no bacteria were found in distributed products. The Centers for Disease Control and Prevention (CDC) advises patients to breastfeed when possible, clean and sanitize hands and feeding items, use liquid formula when possible, and safely store the powder formula to prevent Cronobacter sakazakii infection.